Mustafa Turkoz

Mustafa Turkoz, PhD has a diverse work experience in the field of biotechnology and immunology. Mustafa currently holds the position of Head of Immunology at Turn Biotechnologies since 2022. Prior to that, they worked as a Principal Scientist at Allogene Therapeutics from 2021 to 2022. Mustafa also held the role of Scientist at Adicet Bio, Inc from 2019 to 2021, where they developed allogeneic CAR T-cell therapies for the treatment of B cell malignancies and solid tumors. Before that, they worked as a Research Scientist at Eureka Therapeutics, Inc from 2018 to 2019, focusing on TCR-T-cell and CAR-T cell-based therapies.

Dr. Turkoz also has experience in academia, having worked as a Postdoctoral Research Fellow at Stanford University from 2016 to 2018, where they studied T-cell function and gene deletion using single-cell RNA sequencing and CRISPR technology. Mustafa also served as a Postdoctoral Research Fellow at Cincinnati Children's Hospital Medical Center from 2014 to 2016.

Additionally, Dr. Turkoz has been actively involved in scientific conferences and seminars. Mustafa held leadership roles as the Chair and Associate Chair of the Gordon Research Seminars on Notch Signaling in Development, Regeneration, & Disease from 2012 to 2016, providing a platform for young scientists to present and exchange new data and ideas.

Prior to their research and academic positions, Dr. Turkoz worked as a Graduate Research Assistant at Washington University School of Medicine from 2007 to 2014, where they conducted research on the role of Notch signaling in dendritic cells and skin cancer. Mustafa also served as a Graduate Teaching Assistant for Principles of Biology 1 during the same period.

Additionally, Dr. Turkoz gained consulting experience as a Consultant at The BALSA Group in 2013. Overall, their work experience showcases their expertise in immunology, CAR T-cell therapies, gene editing, and scientific leadership.

Mustafa Turkoz, PhD obtained their Bachelor's Degree in Molecular Biology and Genetics from Bilkent University. Following their undergraduate studies, they pursued a Doctor of Philosophy (Ph.D.) degree in Development, Regenerative and Stem Cell Biology at Washington University School of Medicine in St. Louis, completing this program between 2007 and 2014.

In addition to their formal education, Mustafa Turkoz obtained certifications in Mouse Methods 100, 200, and 300 wet labs from Cincinnati Children's Hospital Medical Center in February 2015.